Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

596 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort.
Gisslander K, White A, Aslett L, Hrušková Z, Lamprecht P, Musiał J, Nazeer J, Ng J, O'Sullivan D, Puéchal X, Rutherford M, Segelmark M, Terrier B, Tesař V, Tesi M, Vaglio A, Wójcik K, Little MA, Mohammad AJ; FAIRVASC consortium. Gisslander K, et al. Among authors: tesar v. Lancet Rheumatol. 2024 Nov;6(11):e762-e770. doi: 10.1016/S2665-9913(24)00187-5. Epub 2024 Aug 22. Lancet Rheumatol. 2024. PMID: 39182506
Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitis.
Scott J, White A, Walsh C, Aslett L, Rutherford MA, Ng J, Judge C, Sebastian K, O'Brien S, Kelleher J, Power J, Conlon N, Moran SM, Luqmani RA, Merkel PA, Tesar V, Hruskova Z, Little MA. Scott J, et al. Among authors: tesar v. RMD Open. 2024 Apr 30;10(2):e003962. doi: 10.1136/rmdopen-2023-003962. RMD Open. 2024. PMID: 38688690 Free PMC article.
The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial.
de Zeeuw D, Bekker P, Henkel E, Hasslacher C, Gouni-Berthold I, Mehling H, Potarca A, Tesar V, Heerspink HJ, Schall TJ; CCX140-B Diabetic Nephropathy Study Group. de Zeeuw D, et al. Among authors: tesar v. Lancet Diabetes Endocrinol. 2015 Sep;3(9):687-96. doi: 10.1016/S2213-8587(15)00261-2. Epub 2015 Aug 9. Lancet Diabetes Endocrinol. 2015. PMID: 26268910 Clinical Trial.
The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial.
Odler B, Riedl R, Geetha D, Szpirt WM, Hawley C, Uchida L, Wallace ZS, Walters G, Muso E, Tesar V, Pusey CD, Little MA, Merkel PA, Walsh M, Jayne DRW, Kronbichler A; PEXIVAS Investigators. Odler B, et al. Among authors: tesar v. Kidney Int. 2024 Dec 19:S0085-2538(24)00911-6. doi: 10.1016/j.kint.2024.11.029. Online ahead of print. Kidney Int. 2024. PMID: 39708998 Free article.
Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy.
Barratt J, Barbour SJ, Brenner RM, Cooper K, Wei X, Eren N, Floege J, Jha V, Kim SG, Maes B, Phoon RKS, Singh H, Tesař V, Lafayette R; ORIGIN Phase 2b Investigators. Barratt J, et al. Among authors: tesar v. J Am Soc Nephrol. 2024 Oct 26:10.1681/ASN.0000000541. doi: 10.1681/ASN.0000000541. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 39462308
596 results